Ordin nr. 1301/500/2008 din 11 iulie 2008 Partea a ii-a

Se aplică tuturor denumirilor comerciale, formelor farmaceutice şi concentraţiilor corespunzătoare DCI-ului.
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

G03GA06 FOLLITROPINUM BETA SOL. INJ. 100 UI/0.5 ml

PUREGON 100 UI/0,5 ml 100 UI/0.5 ml N.V. ORGANON
G03GA06 FOLLITROPINUM BETA SOL. INJ. 300 UI/0.36 ml

PUREGON 300 UI/0,36 ml 300 UI/0.36 ml N.V. ORGANON

G03GA06 FOLLITROPINUM BETA SOL. INJ. 50 UI/0.5 ml

PUREGON 50 UI/0,5 ml 50 UI/0.5 ml N.V. ORGANON

G03GA06 FOLLITROPINUM BETA SOL. INJ. 600 UI/0.72 ml

PUREGON 600 UI/0.72 ml 600 UI/0.72 ml N.V. ORGANON

G03GA06 FOLLITROPINUM BETA PULB + SOLV. PT. SOL. 100 UI/ml

INJ.

PUREGON 100 UI 100 UI/ml ORGANON NV
G03GA06 FOLLITROPINUM BETA PULB + SOLV. PT. SOL. 50 UI/ml

INJ

PUREGON 50 UI 50 UI/ml ORGANON NV
______________________________________________________________________________

| 271 |G03GB02| CLOMIFENUM | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

G03GB02 CLOMIFENUM COMPR. 50 mg

CLOSTILBEGYT 50 mg EGIS PHARMACEUTICALS PLC

OVA-MIT 50 mg REMEDICA LTD.

Prescriere limitată: Infertilitate anovulatorie
______________________________________________________________________________

| 272 |G03XC01| RALOXIFENUM | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

G03XC01 RALOXIFENUM COMPR. FILM. 60 mg

EVISTA 60 mg 60 mg ELI LILLY NEDERLAND BV
Cod restricţie 3006: Monoterapie cu medicamente antiresorbtive pentru tratamentul şi profilaxia osteoporozei sexoidoprive la femei până la vârsta de 60 ani.
NOTĂ:

Agenţii antiresorbtivi utilizaţi în tratamentul osteoporozei instalate sunt: ALENDRONATE SODIUM, RISEDRONAT SODIUM, RALOXIFEN HYDROCHLORIDE, IBANDRONATE, ZOLENDRONATE ŞI STRONTIUM RANELATE (agent antiresorbtiv şi formator osos).
______________________________________________________________________________

| 273 |G04BD04| OXYBUTYNINUM | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

G04BD04 OXYBUTYNINUM COMPR. 5 mg

DRIPTANE(R) 5 mg 5 mg LAB. FOURNIER SA
Prescriere limitată: Hipereactivitate a detrusorului
______________________________________________________________________________

| 274 |G04BD07| TOLTERODINUM**# | Protocol: G010N |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

G04BD07 TOLTERODINUM CAPS. ELIB. PREL. 4 mg

DETRUSITOL SR 4 mg 4 mg PFIZER EUROPE MA EEIG
______________________________________________________________________________

| 275 |G04BD08| SOLIFENACINUM SUCCINATE**# | Protocol: G009N |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

G04BD08 SOLIFENACINUM COMPR. FILM. 10 mg

SUCCINATE

VESICARE 10 mg 10 mg ASTELLAS PHARMA EUROPE

B.V.

G04BD08 SOLIFENACINUM COMPR. FILM. 5 mg

SUCCINATE

VESICARE 5 mg 5 mg ASTELLAS PHARMA EUROPE

B.V.
______________________________________________________________________________

| 276 |G04BD09| TROSPIUM | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

G04BD09 TROSPIUM COMPR. FILM. 15 mg

INKONTAN 15 mg 15 mg PHARMAZEUTISCHE FABRIK

MONTAVIT GES. M.B.H.

G04BD09 TROSPIUM COMPR. FILM. 30 mg

INKONTAN 30 mg 30 mg PHARMAZEUTISCHE FABRIK

MONTAVIT GES. M.B.H.
______________________________________________________________________________

| 277 |G04CA01| ALFUZOSINUM | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

G04CA01 ALFUZOSINUM COMPR. ELIB. PREL. 10 mg

ALFURAN MR 10 mg 10 mg TERAPIA S.A.

XATRAL SR 10 mg 10 mg SANOFI-SYNTHELABO FRANCE

G04CA01 ALFUZOSINUM COMPR. FILM. ELIB. 5 mg

PREL.

XATRAL(R) LP 5 mg 5 mg SANOFI-SYNTHELABO FRANCE
______________________________________________________________________________

| 278 |G04CA02| TAMSULOSINUM | |

|_______|_______|____________________________________________|_________________|
Prescriere limitată: Tratamentul hiperplaziei benigne de prostată.